Inherited mutations in the gene BRCA2 significantly increase the risk of carriers to breast and ovarian cancers. BRCA2, a crucial player in the body's DNA repair system, aids in repairing damaged DNA.

The University's Anticancer Discovery from Pets to People has found success with a new drug that has treated cancer in pets.

The Horner–Wadsworth–Emmons (HWE) reaction is a fundamental reaction in organic chemistry, widely used to create conjugated carbonyl compounds. Conjugated carbonyl compounds are used in many ...

“My appointment to serve on the NIH Drug Discovery and Molecular Pharmacology Study Section is an immense honor and a significant milestone in my career,” says Woo. “It signifies recognition of my ...

SCOTTSDALE, Ariz. — Feb. 18, 2025 — Sunil Sharma, M.D., MBA, one of the nation’s leading experts in creating anti-cancer drugs, has been named director of HonorHealth Research Institute’s new Center ...

(Top) Melanoma develops resistance to BRAF inhibitors, leading to cancer recurrence. (Bottom) By combining polyamine biosynthesis inhibition with BRAF inhibitors, the recurrence of cancer can be ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Last year, obesity treatment drug sales surpassed the immune anticancer drug ‘Kitruda,’ which had long held the top sales position. On the 8th, Eugene Investment & Securities estimated this in a ...

The National Institutes of Health (NIH) Center for Scientific Review has appointed Sukyung Woo, PhD, associate professor, Department of Pharmaceutical Sciences, to serve as a member of its Drug ...